Table 1.
Past reports of sclerosing mucoepidermoid carcinoma
| Source | Age (years) | Gender | Site | Size (cm) | Grade | Treatment | Follow-up | TATE |
|---|---|---|---|---|---|---|---|---|
| Chan and Saw [3] | 36 | F | Parotid gland | 6×3×2 | Low | Superficial parotidectomy | NA | − |
| Muller et al. [4] | 17 | F | Parotid gland | 2 | Intermediate | Total parotidectomy | NA | + |
| Muller et al. [4] | 60 | F | Parotid gland | 4.5×4 | Intermediate | Resection + RT | NA | + |
| Sinha et al. [5] | 65 | M | Minor salivary glands (parapharyngeal space) | 5×4×3 | High | Resection +RT | NA | − |
| Urano et al. [6] | 57 | F | Parotid gland | 2.5×2 | Low | Superficial parotidectomy | Lymph node metastasis/3y | + |
| Urano et al. [6] | 43 | M | Submandibular gland | 4.5×2.5 | Low | Total excision of submandibular gland | Dead of disease/7y | + |
| Fadare et al. [7] | 44 | F | Parotid gland | 4×2 | Low | Total parotidectomy + RT | NED/7y | − |
| Ide et al. [8] | 28 | M | Minor salivary glands (retromolar pad) | 2×2 | Intermediate | Total excision | NA | + |
| Heavner et al. [9] | 23 | F | Parotid gland | 2×1 | Low | Total parotidectomy + RT | NED/1y | + |
| Veras et al. [10] | 70 | F | Parotid gland | 4×3 | Low | Superficial parotidectomy | Dead of other disease/11y | + |
| Veras et al. [10] | 37 | M | Parotid gland | 2.2×1×1 | Low | Superficial parotidectomy | NED/17y | + |
| Veras et al. [10] | 49 | F | Parotid gland | 2.6×1.7 | Low | Superficial parotidectomy | NED/4mo | + |
| Veras et al. [10] | 16 | F | Parotid gland | 2×2 | Intermediate | Superficial parotidectomy | NED/10mo | + |
| Aguiar et al. [11] | 43 | F | Minor salivary glands (palate) | 4×4 | Low | Partial maxillectomy | NED/19mo | + |
| Shinhar [12] | 57 | F | Parotid gland | 2 | Intermediate | Superficial parotidectomy + RT | NED/3y | − |
| Mendelson et al. [13] | 21 | F | Parotid gland | 2 | Low | Total parotidectomy + level-II neck dissection | NED/3y | − |
| Tian et al. [14] | 42 | F | Parotid gland | 1.5 | Low | Local excision | NED/19mo | − |
| Tian et al. [14] | 52 | F | Parotid gland | 1.4 | Low | Local excision | NED/31mo | − |
| Tian et al. [14] | 62 | F | Parotid gland | 2 | Low | Local excision | Lost to follow-up | − |
| Tian et al. [14] | 28 | M | Parotid gland | 1.2 | Low | Local excision | NED/8mo | − |
| Tian et al. [14] | 65 | F | Parotid gland | 1.5 | Low | Local excision | NED/4mo | − |
| Tian et al. [14] | 32 | M | Submandibular gland | 1.1 | Low | Local excision | Lost to follow-up | − |
| Tasaki et al. [15] | 79 | M | Submandibular gland | 5.6 | Low | Total excision of submandibular gland | NED/15mo | + |
| Current case | 61 | M | Minor salivary glands (upper lip) | 1.2×0.9 | Intermediate | Resection | Local recurrence/30mo | + |
F, female; M, male; mo, month(s); NA, not available; NED, no evidence of disease; RT, radiotherapy; TATE, tumor-associated tissue eosinophilia; y, year(s).